Skip to main content
. 2013 Jun;15(2):213–224. doi: 10.31887/DCNS.2013.15.2/lripoll

Table I. Antidepressants demonstrating efficacy in borderline personality disorder. MAOI, monoamine oxidase inhibitor; SSRIs, selective serotonin reuptake inhibitors.

Medication Dosing Effects
MAOIs
Phenelzine 15-90 mg/d Improvements primarily in depression, impulsive aggression. Some patients experience uncomfortable activation.
Tranylcypromine Mean dose 40 mg/d Improvements primarily in affective symptoms, interpersonal sensitivity, but limited data.
SSRIs
Fluoxetine 20-80 mg/d Mild improvements in affective symptoms, anger, impulsive aggression. Effects may be pronounced in males, patients with high levels of impulsive aggression.
Fluvoxamine 150-250 mg/d Mild improvement in affective instability, not impulsivity.
Paroxetine 20-40 mg/d Possible decrease in suicidality without significant effect on depression, though limited data.